0001722820-17-000001.txt : 20171120 0001722820-17-000001.hdr.sgml : 20171120 20171120103935 ACCESSION NUMBER: 0001722820-17-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20171120 DATE AS OF CHANGE: 20171120 EFFECTIVENESS DATE: 20171120 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Exonics Therapeutics, Inc. CENTRAL INDEX KEY: 0001722820 IRS NUMBER: 814846817 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-299113 FILM NUMBER: 171212911 BUSINESS ADDRESS: STREET 1: 1 BROADWAY STREET 2: 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 781-749-3987 MAIL ADDRESS: STREET 1: 1 BROADWAY STREET 2: 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 D 1 primary_doc.xml X0708 D LIVE 0001722820 Exonics Therapeutics, Inc. 1 BROADWAY 14TH FLOOR CAMBRIDGE MA MASSACHUSETTS 02142 781-749-3987 DELAWARE None None Corporation true 2016 John Ripple 1 Broadway 14th Floor Cambridge MA MASSACHUSETTS 02142 Executive Officer Director H. James Magee 1 Broadway 14th Floor Cambridge MA MASSACHUSETTS 02142 Executive Officer David Goeddel 1 Broadway 14th Floor Cambridge MA MASSACHUSETTS 02142 Director JeenJoo Kang 1 Broadway 14th Floor Cambridge MA MASSACHUSETTS 02142 Director Biotechnology Decline to Disclose 06b false 2017-11-07 true true false 0 42043965 22043962 20000003 false 2 0 0 0 false Exonics Therapeutics, Inc. /s/ John Ripple John Ripple President and CEO 2017-11-20